Scientific articles 17 Dec 2025 Kronopolitides A–F, a family of 36-membered polyol macrolides with antiparasitic activity against Chagas disease Journal of Natural Products
In the media 15 Dec 2025 The biggest mosquito-borne disease in the world has a cure. There’s just one problem Vox
News 4 Dec 2025 Dr Javid Abdelmoneim, Datuk Dr Mahathar bin Abd Wahab, Dr Taruna Madan, Violet Naanyu, and Dr Mario Santos Moreira join the Board of Directors at DNDi
In the media 2 Dec 2025 “Como si me comiera desde dentro”: la enfermedad que ataca los huesos en el norte de Kenia EFE
Scientific articles 2 Dec 2025 The development of a global research agenda and individual participant data platform for visceral leishmaniasis: challenges and future opportunities Parasites & Vectors
Press releases 27 Nov 2025 International seminar explores the development of treatments for dengue for populations not covered by vaccines
News 26 Nov 2025 DNDi statement on the approval of the Instituto Butantan’s dengue vaccine and the need for a dengue treatment
Scientific articles 25 Nov 2025 Bidirectional interaction between liposomal amphotericin B pharmacokinetics and parasite dynamics in patients with post-kala-azar dermal leishmaniasis: Potential implications for optimal dosing Clinical Pharmacology & Therapeutics
Videos 24 Nov 2025 Interview with Dr Pauline Williams, new DNDi Scientific Advisory Committee (SAC) Chair
Scientific articles 20 Nov 2025 Safety, tolerability and pharmacokinetics of DNDI-6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participants British Journal of Clinical Pharmacology
Press releases 2 Feb 2023 Dutch government renews support to DNDi projects on poverty-related diseases that disproportionately impact women
Press releases 14 Dec 2022 Launch of first platform for emergency research preparedness and response in Africa
Press releases 1 Dec 2022 DNDi partners in a new NIHR-funded Global Health Research Group on HIV-associated Fungal Infections (IMPRINT)
Press releases 30 Nov 2022 Acoziborole: Investigational single-dose oral treatment raises hope for elimination of sleeping sickness in Africa
Press releases 15 Nov 2022 Leishmaniasis project launched in Eastern Africa to improve patient access to treatments
Press releases 6 Oct 2022 Le Canton de Genève soutient la recherche sur le mycétome, l’une des maladies les plus négligées au monde
Press releases 29 Sep 2022 Better, shorter combination treatment for people with visceral leishmaniasis shown to be effective in Eastern Africa
Press releases 5 Sep 2022 Dr Luis Pizarro becomes new Executive Director of the Drugs for Neglected Diseases initiative
Press releases 30 Aug 2022 Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and DNDi to explore joint opportunities to develop affordable and life-saving new drugs for neglected tropical diseases
Press releases 3 Aug 2022 Network of experts calls for urgent boost to research and development of rapid tests for cutaneous leishmaniasis in Latin America
Press releases 27 Jul 2022 Korean cutting-edge technology to reduce the cost of promising drug for neglected disease visceral leishmaniasis
Press releases 6 Jul 2022 Wellcome renews partnership with DNDi to develop new generation drugs to treat leishmaniasis
Press releases 5 Jul 2022 Brazil joins ANTICOV trial to find early treatments for people with mild-to-moderate COVID-19
Press releases 29 Jun 2022 DNDi welcomes new PAHO recommendations for the treatment of leishmaniasis in the Americas
Press releases 14 Jun 2022 Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for young children living with HIV in South Africa
